Formations of, Acquisitions by, and Mergers of Bank Holding Companies, 71067 [2021-27044]

Download as PDF Federal Register / Vol. 86, No. 237 / Tuesday, December 14, 2021 / Notices Complainant alleges that Respondent violated 46 U.S.C. § 41102(c) and 46 U.S.C. 41104(a)(3) and (8) with regard to the movement of refrigerated containers. The full text of the complaint can be found in the Commission’s Electronic Reading Room at https://www2.fmc.gov/ readingroom/proceeding/21-10/. This proceeding has been assigned to Office of Administrative Law Judges. The initial decision of the presiding office in this proceeding shall be issued by December 8, 2022, and the final decision of the Commission shall be issued by June 22, 2023. 2200 North Pearl Street, Dallas, Texas 75201–2272: 1. The Odom AmTex Holdings Trust, Orange, Texas; to become a bank holding company by acquiring Odom AmTex, LLC, Orange, Texas, and thereby indirectly acquiring AmTex Bancshares, Inc., Orange, Texas; Bridge City State Bank, Bridge City, Texas; Peoples State Bank, Shepherd, Texas; and Pavillion Bank, Richardson, Texas. Board of Governors of the Federal Reserve System, December 9, 2021. Michele Taylor Fennell, Deputy Associate Secretary of the Board. [FR Doc. 2021–27044 Filed 12–13–21; 8:45 am] JoAnne O’Bryant, Program Analyst. BILLING CODE 6210–01–P [FR Doc. 2021–26992 Filed 12–13–21; 8:45 am] BILLING CODE 6730–02–P jspears on DSK121TN23PROD with NOTICES1 DEPARTMENT OF HEALTH AND HUMAN SERVICES FEDERAL RESERVE SYSTEM Centers for Disease Control and Prevention Formations of, Acquisitions by, and Mergers of Bank Holding Companies [Docket No. CDC–2021–0132] The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The public portions of the applications listed below, as well as other related filings required by the Board, if any, are available for immediate inspection at the Federal Reserve Bank(s) indicated below and at the offices of the Board of Governors. This information may also be obtained on an expedited basis, upon request, by contacting the appropriate Federal Reserve Bank and from the Board’s Freedom of Information Office at https://www.federalreserve.gov/foia/ request.htm. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). Comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors, Ann E. Misback, Secretary of the Board, 20th Street and Constitution Avenue NW, Washington DC 20551–0001, not later than December 30, 2021. A. Federal Reserve Bank of Dallas (Karen Smith, Director, Applications) VerDate Sep<11>2014 18:24 Dec 13, 2021 Jkt 256001 Advisory Committee on Immunization Practices (ACIP); Meeting Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting and request for comment. AGENCY: In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces the following meeting of the Advisory Committee on Immunization Practices (ACIP). This meeting is open to the public. Time will be available for public comment. The meeting will be webcast live via the World Wide Web. DATES: The meeting will be held on January 12, 2022, from 10:00 a.m. to 2:30 p.m., EST (times subject to change). The public may submit written comments from December 14, 2021 through January 12, 2022. ADDRESSES: You may submit comments identified by Docket No. CDC–2021– 0132 by any of the following methods: • Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. • Mail: Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H24–8, Atlanta, Georgia 30329– 4027, Attn: ACIP Meeting. Instructions: All submissions received must include the Agency name and Docket Number. All relevant comments received in conformance with the https://www.regulations.gov suitability policy will be posted without change to https://www.regulations.gov, including SUMMARY: PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 71067 any personal information provided. For access to the docket to read background documents or comments received, go to https://www.regulations.gov. Written public comments submitted up to 72 hours prior to the ACIP meeting will be provided to ACIP members before the meeting. FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee Management Specialist, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS–H24–8, Atlanta, Georgia 30329– 4027; Telephone: (404) 639–8367; Email: ACIP@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The committee is charged with advising the Director, CDC, on the use of immunizing agents. In addition, under 42 U.S.C. 1396s, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children program, along with schedules regarding dosing interval, dosage, and contraindications to administration of vaccines. Further, under provisions of the Affordable Care Act, section 2713 of the Public Health Service Act, immunization recommendations of the ACIP that have been approved by the CDC Director and appear on CDC immunization schedules must be covered by applicable health plans. Matters To Be Considered: The agenda will include discussions on cholera vaccine, tick-borne encephalitis vaccine, influenza vaccines, hepatitis vaccines and respiratory syncytial virus (RSV) vaccine. No recommendation votes are scheduled. No Vaccines for Children (VFC) votes are scheduled. Agenda items are subject to change as priorities dictate. For more information on the meeting agenda visit https:// www.cdc.gov/vaccines/acip/meetings/ meetings-info.html. Public Participation Interested persons or organizations are invited to participate by submitting written views, recommendations, and data. Please note that comments received, including attachments and other supporting materials, are part of the public record and are subject to public disclosure. Comments will be posted on https://www.regulations.gov. Therefore, do not include any information in your comment or supporting materials that you consider confidential or inappropriate for public disclosure. If you include your name, E:\FR\FM\14DEN1.SGM 14DEN1

Agencies

[Federal Register Volume 86, Number 237 (Tuesday, December 14, 2021)]
[Notices]
[Page 71067]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-27044]


=======================================================================
-----------------------------------------------------------------------

FEDERAL RESERVE SYSTEM


Formations of, Acquisitions by, and Mergers of Bank Holding 
Companies

    The companies listed in this notice have applied to the Board for 
approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 
1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other 
applicable statutes and regulations to become a bank holding company 
and/or to acquire the assets or the ownership of, control of, or the 
power to vote shares of a bank or bank holding company and all of the 
banks and nonbanking companies owned by the bank holding company, 
including the companies listed below.
    The public portions of the applications listed below, as well as 
other related filings required by the Board, if any, are available for 
immediate inspection at the Federal Reserve Bank(s) indicated below and 
at the offices of the Board of Governors. This information may also be 
obtained on an expedited basis, upon request, by contacting the 
appropriate Federal Reserve Bank and from the Board's Freedom of 
Information Office at https://www.federalreserve.gov/foia/request.htm. 
Interested persons may express their views in writing on the standards 
enumerated in the BHC Act (12 U.S.C. 1842(c)).
    Comments regarding each of these applications must be received at 
the Reserve Bank indicated or the offices of the Board of Governors, 
Ann E. Misback, Secretary of the Board, 20th Street and Constitution 
Avenue NW, Washington DC 20551-0001, not later than December 30, 2021.
    A. Federal Reserve Bank of Dallas (Karen Smith, Director, 
Applications) 2200 North Pearl Street, Dallas, Texas 75201-2272:
    1. The Odom AmTex Holdings Trust, Orange, Texas; to become a bank 
holding company by acquiring Odom AmTex, LLC, Orange, Texas, and 
thereby indirectly acquiring AmTex Bancshares, Inc., Orange, Texas; 
Bridge City State Bank, Bridge City, Texas; Peoples State Bank, 
Shepherd, Texas; and Pavillion Bank, Richardson, Texas.

    Board of Governors of the Federal Reserve System, December 9, 
2021.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2021-27044 Filed 12-13-21; 8:45 am]
BILLING CODE 6210-01-P